Currently out of the existing stock ratings of Ilya Zubkov, 9 are a BUY (81.82%), 2 are a HOLD (18.18%).

Ilya Zubkov

Work Performance Price Targets & Ratings Chart

Analyst Ilya Zubkov, currently employed at FREEDOM CAPITAL MARKETS, carries an average stock price target met ratio of 60.42% that have a potential upside of 47.86% achieved within 67 days.

Ilya Zubkov’s has documented 22 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on LFMD, LifeMD at 12-Mar-2026.

Wall Street Analyst Ilya Zubkov

Analyst best performing recommendations are on VNRX (VOLITIONRX LTD).
The best stock recommendation documented was for LFMD (LIFEMD) at 3/18/2025. The price target of $13 was fulfilled within 90 days with a profit of $7.35 (130.09%) receiving and performance score of 14.45.

Average potential price target upside

BDTX Black Diamond Therapeutics CADL Candel Therapeutics ISRG Intuitive Surgical JNJ Johnson & Johnson LFMD LifeMD LGCY Legacy Education LLY Eli Lilly and Company VNRX Volitionrx Ltd

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 22-Nov-2023

$11

$9.29 (543.27%)

$10

4 months 15 days ago
(29-Apr-2026)

0/13 (0%)

$8.43 (328.02%)

Buy Since 12-Sep-2023

$14

$12.29 (718.71%)

$16

5 months 27 days ago
(17-Mar-2026)

0/10 (0%)

$11.77 (527.80%)

Buy Since 18-Nov-2025

$8

$6.29 (367.84%)

$9

7 months 28 days ago
(16-Jan-2026)

0/2 (0%)

$5.44 (212.50%)

Buy Since 14-Dec-2023

9 months 9 days ago
(04-Dec-2025)

1/6 (16.67%)

$5.12 (177.78%)

83

Buy Since 31-Jul-2024

$8

10 months 28 days ago
(16-Oct-2025)

0/2 (0%)

$3.85 (92.77%)

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Ilya Zubkov?

On 2025

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?